Transgenic and Knockout Mouse Resource
转基因和基因敲除小鼠资源
基本信息
- 批准号:7623562
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdvanced Malignant NeoplasmAnimal ModelBiologicalCancer CenterCausationsConsultCost SavingsDerivation procedureES Cell LineEmbryoFoundationsFutureGene TargetingGenesGoalsHumanJournalsKnockout MiceMalignant NeoplasmsMicroinjectionsMolecularMusMutatePathogenesisPeer ReviewPlantsProductionPublicationsRateReagentResearchResearch PersonnelResource SharingResourcesRoleScientific Advances and AccomplishmentsServicesStem Cell ResearchStem cellsSystemTechnologyTransgenic Organismsanticancer researchblastocystcostembryonic stem cellin vivomedical schoolsmembermouse genomemouse modelprogramssomatic cell nuclear transfertool
项目摘要
The Transgenic and Knockout Mouse Shared Resource was established in 1996 at the School of
Medicine. The overall objective of this Shared Resource is to provide genetically modified mouse
models and supporting technologies to Stanford Cancer Center investigators at cost-effective rates. This
Shared Resource provides the necessary scientific and technical foundation and physical plant to
conduct transgenic, gene targeting and embryonic stem cell research. The Shared Resource serves an
important role in advancing cancer research by providing a wide spectrum of mouse embryo and stem
cell manipulation and microinjection services to investigators as a highly specialized technology. The
objectives of the Shared Resource are to:
¿ Consult in all aspects of creating and characterizing genetically modified mice
¿ Produce transgenic and knockout mice by microinjection
¿ Manipulate mouse embryonic stem cells for gene targeting
¿ Provide molecular and biological reagents associated with production of genetically modified mice
Substantial cost savings, efficiencies and scientific advances accrue from providing these services
through a centralized facility. The Shared Resource has generated over 500 mouse models in the last 5
years, each with multiple independent lines. The Shared Resource's services were acknowledged in
more than 50 publications in peer-reviewed journals. In fiscal year 2005, there were 192 service requests,
with Cancer Center members accounting for 56% of overall use. Cancer Center members representing
eight out of ten Programs utilized the Shared Resource. Future plans for the Shared Resource include
implementation of somatic cell nuclear transfer and tetraploid blastocyst complementation services, and
derivation of new ES cell lines.
转基因和基因敲除小鼠共享资源于1996年在哈佛大学建立。
药本共享资源的总体目标是提供转基因小鼠
以具有成本效益的价格向斯坦福大学癌症中心的研究人员提供模型和支持技术。这
共享资源为实现可持续发展提供了必要的科学技术基础和物质基础,
开展转基因、基因打靶和胚胎干细胞研究。共享资源服务于
通过提供广泛的小鼠胚胎和干细胞在推进癌症研究中发挥重要作用
细胞操作和显微注射服务作为一种高度专业化的技术。的
共享资源的目标是:
在创建和表征转基因小鼠的各个方面提供咨询
通过显微注射生产转基因和基因敲除小鼠
操作小鼠胚胎干细胞用于基因靶向
<$提供与转基因小鼠生产相关的分子和生物试剂
通过提供这些服务,可以节省大量费用,提高效率,促进科学进步
通过一个集中的设施。在过去的5年里,共享资源已经生成了500多个鼠标模型。
年,每个都有多个独立的行。共享资源的服务得到了
在同行评审期刊上发表了50多篇论文。在2005财政年度,有192项服务请求,
其中癌症中心成员占总使用量的56%。癌症中心成员代表
十个程序中有八个使用了共享资源。共享资源的未来计划包括
实施体细胞核移植和四倍体胚泡互补服务,以及
新ES细胞系的衍生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruby Yanru Chen-Tsai其他文献
Ruby Yanru Chen-Tsai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruby Yanru Chen-Tsai', 18)}}的其他基金
Targeted Gene Insertion by Directed Evolution of ΦC31 Integrase for Therapeutic Gene Editing
通过 κC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
9906961 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
通过 αC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
10177096 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
通过 αC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
10227267 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
Development of novel rat models for site-specific transgene integration
开发用于位点特异性转基因整合的新型大鼠模型
- 批准号:
8643473 - 财政年份:2014
- 资助金额:
$ 4.2万 - 项目类别:














{{item.name}}会员




